The Bayer activities of daily living scale (B-ABL)

被引:351
作者
Hindmarch, I
Lehfeld, H
de Jongh, P
Erzigkeit, H
机构
[1] Univ Surrey, Human Psychopharmacol Res Unit, Godalming GU7 1UF, Surrey, England
[2] Univ Erlangen Nurnberg, Hosp Psychiat, D-8520 Erlangen, Germany
[3] Bayer AG, D-5090 Leverkusen, Germany
关键词
B-ADL; activities of daily living; therapy evaluation; dementia screening; Alzheimer's disease; vascular dementia; mild cognitive impairment;
D O I
10.1159/000051195
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The Bayer Activities of Daily Living Scale (B-ADL) has been developed on an international basis to assess deficits in the performance of everyday activities. The scale's main target group is community dwelling patients who suffer mild cognitive impairment or mild-to-moderate dementia. It comprises 25 items and takes the form of a questionnaire to be completed by a caregiver or other informant sufficiently familiar with the patient. Statistical, clinical and domain-related criteria were used to select items from among a large number of activities of daily living (ADL) questions field tested in pilot studies in the USA, Germany, UK, Russia and Greece. The items included in the B-ADL have been chosen for their sensitivity to cognitive impairment, simplicity of concept, international applicability and their relevance to patients coping with the demands of everyday life. The scale uses items which reflect a wide range of domains. On account of its brevity, it is thought especially suitable for application within a GP and primary care context for. both screening a patient's ADL capacities as well as for documentation of treatment effects and the progress of dementia. This paper focuses on a description of the scale and its application.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 23 条
[1]   INSTRUMENTAL ACTIVITIES OF DAILY LIVING AS A SCREENING TOOL FOR COGNITIVE IMPAIRMENT AND DEMENTIA IN ELDERLY COMMUNITY DWELLERS [J].
BARBERGERGATEAU, P ;
COMMENGES, D ;
GAGNON, M ;
LETENNEUR, L ;
SAUVEL, C ;
DARTIGUES, JF .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1992, 40 (11) :1129-1134
[2]  
Brislin R.W., 1986, FIELD METHOD CROSS C, P137, DOI DOI 10.1177/017084068800900318
[3]  
*CLIN RES WORK GRO, 1990, DEMENTIA, V1, P292
[4]  
*COMM PROPR MED PR, 1997, NOT GUID MED PROD TR
[5]  
CURRAN S, 1997, PRIMARY CARE PSYCHIA, V3, P151
[6]  
ERZIGKEIT H, 1995, AGING HLTH HEALING, P359
[7]  
Finkel SI, 1996, HUM PSYCHOPHARM CLIN, V11, P439, DOI 10.1002/(SICI)1099-1077(199611)11:6<439::AID-HUP810>3.0.CO
[8]  
2-K
[9]  
Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33
[10]  
Gauthier S, 1997, ALZ DIS ASSOC DIS, V11, P6